Home › Funds › Casdin Capital › EDIT

Casdin Capital position in EDIT

EDITAS MEDICINE INC · Health Care

Casdin Capital reported holding 445,000 shares of EDIT (EDITAS MEDICINE INC) in its Q3 2026 13F filing — a position valued at US$1.1M, representing 0.05% of its reported portfolio and ranking #42 among its reported holdings. Casdin Capital has disclosed EDIT holdings in 16 of the last 43 reported quarters, going back to Q1 2016.

Latest position (Q3 2026)445.00K sh
Reported value held$1.14M
Portfolio Weight0.05%
First reportedQ1 2016
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Casdin Capital's EDIT position evolved

Casdin Capital first disclosed a stake in EDIT in Q1 2016 at 85,470 shares (US$3.0M). The position peaked in Q2 2019 at 480,000 shares, worth US$11.88B. Across 16 filings, Casdin Capital increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 445,000 shares valued at US$1.1M. Notable position changes include a 105% increase in Q1 2017, a 34% increase in Q2 2018, a 158% increase in Q3 2018.

Quarter by quarter

QuarterSharesValueChange
Q1 2016 85.47K $2.95M New
Q3 2016 85.47K $1.15M New
Q4 2016 65.00K $1.05M Reduce
Q1 2017 133.33K $2.98M Add
Q2 2017 133.33K $2.24M Hold
Q3 2017 133.33K $3.20M Hold
Q4 2017 133.33K $4.10M Hold
Q1 2018 133.33K $4.42M Hold
Q2 2018 178.33K $6.39M Add
Q3 2018 460.00K $14.64M Add
Q4 2018 480.00K $10.92M Add
Q1 2019 480.00K $11.74M Hold
Q2 2019 480.00K $11.88B Hold
Q3 2019 415.00K $9.44B Reduce
Q2 2026 445.00K $1.44M New
Q3 2026 445.00K $1.14M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EDIT and 13F data

EDIT (EDITAS MEDICINE INC) is a Health Care company. 37 other funds we track also report a position in EDIT — the largest reported positions include TCG Crossover Management, LLC (US$28.6M), ADAR1 Capital Management, LLC (US$22.8M), Commodore Capital LP (US$22.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EDIT

All EDIT fund holders →

FAQ

How long has Casdin Capital held EDIT?

Casdin Capital has disclosed EDIT holdings in 16 of the last 43 reported quarters, going back to Q1 2016.

What is Casdin Capital's current position in EDIT?

As of Q3 2026, Casdin Capital holds 445.00K shares of EDIT (EDITAS MEDICINE INC), valued at $1.14M, representing 0.05% of its reported portfolio and ranking #42.

Has Casdin Capital been buying or selling EDIT?

In the latest 13F filing (Q3 2026), Casdin Capital held unchanged its position in EDIT. The position peaked in Q2 2019 at 480.00K shares.

Which other funds hold EDIT?

Other major institutional holders of EDIT include TCG Crossover Management, LLC, ADAR1 Capital Management, LLC, Commodore Capital LP, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.